TEVOGEN BIO HLDGS INC COM - Stock (LGST)

CUSIP: G8028L107

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Stock
Total 13F shares
31,308,187
Share change
+4,150,344
Total reported value
$313,417,000
Price per share
$10.01
Number of holders
67
Value change
+$41,563,515
Number of buys
18
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP G8028L107?
CUSIP G8028L107 identifies LGST - TEVOGEN BIO HLDGS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEVOGEN BIO HLDGS INC COM - Stock (LGST) as of Q2 2022

As of 30 Jun 2022, TEVOGEN BIO HLDGS INC COM - Stock (LGST) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,308,187 shares. The largest 10 holders included Saba Capital Management, L.P., Corbin Capital Partners, L.P., FourWorld Capital Management LLC, MILLENNIUM MANAGEMENT LLC, Polar Asset Management Partners Inc., HSBC HOLDINGS PLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Weiss Asset Management LP, ARISTEIA CAPITAL LLC, and Taconic Capital Advisors LP. This page lists 67 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.